Loyens & Loeff is known for handling a broad range of matters in the healthcare and life sciences arena, including advising on clinical trials, investments, procurement cases and competition issues. Kim Lucassen leads the firm's data protection and privacy practice and is active in life sciences and healthcare matters; she co-heads the department with Vincent van der Lans, a key contact for M&A work and multi-jurisdictional restructurings, and the 'highly skilled' Tom van Helmond, who handles a wide spectrum of procurement and competition law issues. Dieuwke Hooft Graafland's 'knowledge of legislation in her field of expertise is remarkable'. Hamza Zourakhti left the firm in September 2024.
Legal 500 redaktioneller Kommentar
- Profil
- Soziale Medien
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Dieuwke Hooft-Graafland's knowledge of legislation in her field of expertise is remarkable.’
‘Loyens & Loeff provides a high quality of service. The lawyers are specialists in their field.’
‘The team is highly knowledgeable in healthcare and life sciences.’
‘The experts at Loyens & Loeff are accessible, committed, trustworthy and effective. Tom van Helmond and Dieuwke Hooft Graafland are outstanding.’
‘Dieuwke Hooft Graafland is a great lawyer. She is very experienced and keeps her eye on the bigger picture. She delivers on time.’
‘The Healthcare and Life Sciences practice has consistently demonstrated a deep understanding of the unique challenges and opportunities within the life sciences and healthcare industry, offering tailored advice that balances legal expertise with industry knowledge. Their multidisciplinary team combines legal, regulatory, and tax expertise, enabling them to provide integrated solutions that address the full spectrum of challenges in healthcare and life sciences. They have a strong track record of navigating complex regulatory environments, both at national and EU levels.'
‘Tom van Helmond is a highly skilled expert within the Healthcare and Life Sciences team, and what truly makes him exceptional is his combination of technical legal expertise and a deep understanding of the intricacies of the industry. What makes Tom different from others in the field is his commitment to truly understanding his clients' needs. He doesn’t just provide legal advice; he takes the time to learn the nuances of your business and the sector in which you operate, ensuring that his counsel is practical and directly applicable to your goals.'
Kernmandanten
- AstraZeneca
- Zilveren Kruis
- Unilabs
- Bergman Clinics
- Zorgverzekeraars Nederland
- European Investment Bank
- Forbion
- VGZ
- Laurens
- Unilabs
Highlight-Mandate
- Advised Eurazeo S.A on the sale of medical technology company DORC to German company Carl Zeiss Meditec AG.
- Advising healthcare insurers on a range of legal matters concerning the bankruptcy of Co-Med.
- Advised the Orpea Group on restructuring and healthcare regulatory aspects in the Netherlands.
Anwält*innen
Hall of fame
Die Anwält*innen an der Spitze ihres Berufsstands, die aufgrund ihres langjährigen Engagements in marktführender Arbeit von Wettbewerbern und Mandanten gleichermaßen geschätzt und anerkannt werden.
Führende Associates
Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.
Praxisleitung
Tom van Helmond; Kim Lucassen; Vincent van der Lans
Weitere Kernanwält*innen
Dieuwke Hooft Graafland; Aurélie Mingels